Literature DB >> 11337320

Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

R G Steen1, J S Taylor, J W Langston, J O Glass, V R Brewer, W E Reddick, R Mages, E K Pivnick.   

Abstract

BACKGROUND AND
PURPOSE: Mutation of the neurofibromatosis type 1 (NF-1) gene may be associated with abnormal growth control in the brain. Because macrocephaly could be a sign of abnormal brain development and because 30% to 50% of children with NF-1 display macrocephaly in the absence of hydrocephalus, we sought to determine the relationship between macrocephaly and other brain abnormalities in young subjects with NF-1. These subjects were free of brain tumor, epilepsy, or other obvious neurologic problems.
METHODS: We prospectively screened 18 neurologically asymptomatic subjects with NF-1, ages 6 to 16 years, using clinical measures, psychometric testing, conventional MR imaging, and quantitative MR imaging to measure T1.
RESULTS: Cranial circumference was 2 or more SDs above the age norm in seven (39%) of 18 subjects, a frequency of macrocephaly 17-fold higher than normal. Conventional MR imaging showed abnormalities in all 18 children, although there were more extensive abnormalities in subjects with macrocephaly. Macrocephaly in NF-1 was associated with enlargement of multiple brain structures, and brain T1 in macrocephalic subjects was reduced with respect to controls in the genu, frontal white matter, caudate, putamen, thalamus, and cortex. In normocephalic subjects, T1 was reduced only in the genu and splenium. Volumetric analysis showed that macrocephaly was associated specifically with enlargement of white matter volume.
CONCLUSION: Neurologically asymptomatic children with NF-1 showed macrocephaly, cognitive deficit, enlarged brain structures, and abnormally low brain T1. Macrocephaly in children with NF-1 may be associated with characteristic alterations in brain development, marked by more widespread and significant changes in T1, greater enlargement of midline structures, and greater volume of white matter.

Entities:  

Mesh:

Year:  2001        PMID: 11337320      PMCID: PMC8174959     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  46 in total

1.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

Authors:  R M Cawthon; R Weiss; G F Xu; D Viskochil; M Culver; J Stevens; M Robertson; D Dunn; R Gesteland; P O'Connell
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

2.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

3.  The normal brain stem from infancy to old age. A morphometric MRI study.

Authors:  R Raininko; T Autti; S L Vanhanen; A Ylikoski; T Erkinjuntti; P Santavuori
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

4.  Developmental regulation of a neuron-specific neurofibromatosis 1 isoform.

Authors:  D H Gutmann; Y Zhang; A Hirbe
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

5.  Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence.

Authors:  R G Steen; R J Ogg; W E Reddick; P B Kingsley
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

6.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

7.  Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.

Authors:  B D Moore; J M Slopis; D Schomer; E F Jackson; B M Levy
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

8.  Age-related changes in proton T1 values of normal human brain.

Authors:  R G Steen; S A Gronemeyer; J S Taylor
Journal:  J Magn Reson Imaging       Date:  1995 Jan-Feb       Impact factor: 4.813

9.  Precise and accurate measurement of proton T1 in human brain in vivo: validation and preliminary clinical application.

Authors:  R G Steen; S A Gronemeyer; P B Kingsley; W E Reddick; J S Langston; J S Taylor
Journal:  J Magn Reson Imaging       Date:  1994 Sep-Oct       Impact factor: 4.813

10.  Intellectual impairment in neurofibromatosis 1.

Authors:  R E Ferner; R A Hughes; J Weinman
Journal:  J Neurol Sci       Date:  1996-06       Impact factor: 3.181

View more
  26 in total

Review 1.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

2.  Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1.

Authors:  Persefoni N Margariti; Konstantinos Blekas; Frosso G Katzioti; Anastasia K Zikou; Meropi Tzoufi; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 5.315

3.  Age-related findings on MRI in neurofibromatosis type 1.

Authors:  Deepak S Gill; Shelley L Hyman; Adam Steinberg; Kathryn N North
Journal:  Pediatr Radiol       Date:  2006-08-16

4.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

Review 5.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

6.  The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1.

Authors:  Natalie A Pride; Mayuresh S Korgaonkar; Belinda Barton; Jonathan M Payne; Steve Vucic; Kathryn N North
Journal:  Hum Brain Mapp       Date:  2013-07-24       Impact factor: 5.038

7.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

8.  Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.

Authors:  João V Duarte; Maria J Ribeiro; Inês R Violante; Gil Cunha; Eduardo Silva; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

9.  Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.

Authors:  José Roberto Lopes Ferraz Filho; Marcos Pontes Munis; Antonio Soares Souza; Rafael Angelo Sanches; Eni Maria Goloni-Bertollo; Erika Cristina Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2008-01-30

10.  Intercostal aneurysm causing spinal cord compression in an NF1 patient.

Authors:  Varun Puvanesarajah; Ioan A Lina; Jason A Liauw; Alex L Coon; Timothy F Witham
Journal:  Eur Spine J       Date:  2013-04-19       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.